Myriad Genetics Inc. (MYGN)
NASDAQ: MYGNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MYGN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $409.38M
- EPS (TTM)
- -$1.10
- Dividend yield
- None
- Ex-dividend date
- Jul 1, 2009
- 52-week range
- 2.74 – 8.59
- Day range
- 4.12 – 4.32
- Volume / Avg
- 1.60M / 2.01M
- Beta
- —
- Shares outstanding
- 95.65M
- Next earnings
- Nov 2, 2026
52-week range
MYGN stock today
Myriad Genetics (MYGN) closed at $4.28 on Oct 7, essentially unchanged from the prior close, versus the S&P 500's 0.22% decline. Shares are 50.2% below their 52-week high of $8.59, set on Oct 16, 2025 and 56.2% above the 52-week low of $2.74, in the middle of the past year's range. MYGN is down 30.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 43.2%.
Myriad Genetics has posted a net loss over the last twelve months (EPS of -$1.10), so its P/E ratio is not meaningful. Myriad Genetics's next earnings report is expected on Nov 2, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Myriad Genetics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IPO year
- 1995
Earnings
Earnings history- Next report
- Nov 2, 2026
- EPS estimate
- $-0.24
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $1.75
- Ex-dividend date
- Jul 1, 2009
Myriad Genetics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TKNOAlpha Teknova Inc. | 8.71 | -0.46% | $467.62M | vs MYGN |
| NNNNAnbio Biotechnology Class A | 4.90 | 0.00% | $215.07M | vs MYGN |
| IMDXInsight Molecular Diagnostics Inc. | 3.46 | +2.37% | $113.23M | vs MYGN |
| ICCCImmuCell Corporation | 9.69 | -2.81% | $88.01M | vs MYGN |
| ACHVAchieve Life Sciences Inc. | 7.24 | +2.99% | $746.46M | vs MYGN |
| BMRABiomerica Inc. | 1.91 | -10.75% | $8.78M | vs MYGN |
| VNRXVolitionRX Limited | 0.226 | -6.96% | $6.79M | vs MYGN |
| CDIOCardio Diagnostics Holdings Inc. | 1.96 | -2.00% | $5.80M | vs MYGN |
Indexes, lists and sector
Appears in lists
Myriad Genetics stock FAQ
What is Myriad Genetics's stock price today?
MYGN last traded at $4.28 as of Oct 7, 4:00 PM EDT, up 0.00% on the day. Prices are delayed at least 15 minutes.
Does Myriad Genetics pay a dividend?
Yes. Myriad Genetics pays $0.00 per share annually. The most recent dividend of $1.75 had an ex-dividend date of Jul 1, 2009.
When is Myriad Genetics's next earnings date?
Myriad Genetics is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $-0.24.
Has MYGN ever split its stock?
Yes. The most recent MYGN stock split was a 2-for-1 split on Mar 26, 2009, one of 2 splits on record.
What is the MYGN 52-week high?
The 52-week high for MYGN is $8.59 and the 52-week low is $2.74. The stock is currently 50.2% below its high.